North America: +1 617 821 0595 | EU: +32 471 808710 | India: +91 73867 22272contactapsl@aurigenservices.com
About Aurigene Pharmaceutical Services
Aurigene Pharmaceutical Services Limited (APSL) is an integrated partner for global pharma companies. It covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to manufacturing APIs and formulation at commercial scales. It has development laboratories from discovery to clinical phase III for New Chemical and Biological Entities (NCEs/NBEs) and cGMP manufacturing facilities in the UK, Mexico, USA, and India. The technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides, and oligonucleotides. Large molecule discovery services include ADC, MAB, mRNA, CART-T as well as development services in MAB and protein therapeutics.
Oligonucleotide Synthesis
At our state-of-the-art drug discovery facility for oligonucleotide synthesis, our team accelerates your early drug discovery. With years of experience in small molecules, we can design molecules, overcoming bioavailability issues, and devising a fast-forward approach for your oligo targets across therapeutic areas such as oncology, inflammation, and anti-bacterial, etc.
Why Aurigene Pharmaceutical Services for Oligonucleotide Synthesis Services
- Capabilities to perform purification, characterization, biological evaluation and conjugation
- In house custom synthesis of phosphoramidites
- Complex conjugation using click chemistry, Amine-acid, Thiol-maleimide, intramolecular cyclization and SNAr of Oligo amines with Floro
- Ion exchange and reverse phase HPLC
- Integrated Discovery (Synthesis + biological validation)
Aurigene Advantage
20+ years of experience in accelerating drug innovation
Highly experienced scientific and scale-up teams
Global accreditations
Dedicated manufacturing setup withpilot and commercial scale capability
Industry-leading expertise in discovery and CMC services
Strong and sustainable Operations
Advocates of long-term partnerships
Flexible services and business model
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market